Alex Boches

Co-Founder, CEO

2022 - Current

Teal is developing advanced analytics capabilities to better understand aging and age-related disease. Our platform has been developed through years of research by the Wyss-Coray lab at Stanford University and is built on previous discoveries that proteins found in the blood can be used to develop organ-specific markers of age and physiology that reveal functional insights and predict disease progression.

Partner

2021

FORM funds and incubates cutting-edge companies aiming to revolutionize healthcare through science and technology.

Advisor

2021

COO & US General Manager

2019 - 2021

Built and led our US business, establishing Baze as an early leader in personalized nutrition. Our mission was to develop a scientifically backed and validated personalized nutrition platform. Our business model evolved from DTC to B2C2B and after supporting thousands of patients, launching several healthcare partnerships, and weathering Covid, we were acquired by Nature's Way in December 2020.

Director

2015 - 2019

Joined as a founding member of Quid's Healthcare team. We built a $20M ARR business working with the world's leading healthcare companies. We used Quid's Natural Language AI platform to help pharma and healthcare executives better understand patient needs. From these insights, we developed patient-centric strategies that would allow them to better serve patients.

Business Development Lead

2014 - 2014

Pioneering B2B healthcare platform developing one of the first end-to-end communications platform for healthcare. I joined as their first business hire to build out their payer growth strategy and business development function.

Business Analyst

2012 - 2014

Worked on numerous projects for healthcare/Life Science clients. Projects were primarily growth strategy-focused. On my last project, I supported a leading pharma VC in their effort to understand the emerging digital health landscape. This project introduced me to the health innovation world and sparked a passion for tech.

Honors Thesis Work

2008 - 2011

Conducted independent research projects related to the anti-cancer drug Laromustine. Researched the apoptotic pathways induced in cells when exposed to the drug.